FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386543503> ?p ?o ?g. }

• W4386543503 abstract "It is estimated that more than 60 million people in Europe, that is, around 12% of the European population, have at least one tattoo. However, there is still little information on the long-term effects of tattoos. Inks used for tattooing are a mixture of chemicals, with pigments being the main components responsible for the visual effect. The pigments used are not produced specifically as ingredients for tattooing, but mainly/primarily for the needs of industry, where lower purity requirements and quality standards are acceptable. It is therefore necessary to understand the risks associated with tattoos, but also to implement appropriate legal regulations. The aim of this article was to collect and summarise the results of research conducted so far on the type of colourants used in tattoo ink and to analyze the impact of these on human health. In addition, as part of this work, the current legal acts regulating the concentration limits and composition of inks used in tattooing as well as the psychological aspects of tattooing were collected and presented.Scientific reports and articles from renowned journals from 1994 to 2022, relevant review and research publications in PubMed, and Google Scholar were analyzed. To analyze the available research literature, the Web of Science, Scopus, PubMed databases were used. The following keywords were used to search for publications: tattoos, colourants used in tattoos, side effects of tattoos, legal acts, psychological aspects of tattoos.The result of the literature analysis indicates a risk to health and side effects associated with tattooing the body. There are still no standardised test methods to analyze tattoo inks and assess their safety. Although the art of tattooing has been known for millennia, European legal authorities have not yet implemented effective regulations. Currently, tattoo products in Europe are covered by the general REACH regulation (Resolution ResAP, 2008; EU regulation 2020/2081, 2020). on product safety. The new amendment in force since January 4, 2022 introduces concentration limits for certain substances used in tattoo and permanent makeup inks. However, these provisions do not sufficiently protect either the consumer or the tattoo industry.The results of the research indicate a potentially harmful effect on skin health. A more stringent safety assessment of the colourants used for tattooing is recommended, supported by studies and applicable legislation." @default.
• W4386543503 created "2023-09-09" @default.
• W4386543503 creator A5000571424 @default.
• W4386543503 creator A5022285502 @default.
• W4386543503 creator A5045149216 @default.
• W4386543503 creator A5072999518 @default.
• W4386543503 creator A5092826215 @default.
• W4386543503 date "2023-09-01" @default.
• W4386543503 modified "2023-10-16" @default.
• W4386543503 title "Types of colourants used in tattoo and permanent make‐up techniques, legal regulations, health, and psychological aspects of tattooing" @default.
• W4386543503 cites W106190145 @default.
• W4386543503 cites W1567530428 @default.
• W4386543503 cites W1702044844 @default.
• W4386543503 cites W171799228 @default.
• W4386543503 cites W1912828599 @default.
• W4386543503 cites W1972502322 @default.
• W4386543503 cites W200140927 @default.
• W4386543503 cites W2006615330 @default.
• W4386543503 cites W2009217092 @default.
• W4386543503 cites W2022804733 @default.
• W4386543503 cites W2026021856 @default.
• W4386543503 cites W2029465347 @default.
• W4386543503 cites W2036093436 @default.
• W4386543503 cites W2045178071 @default.
• W4386543503 cites W2046341828 @default.
• W4386543503 cites W2068805925 @default.
• W4386543503 cites W2112272188 @default.
• W4386543503 cites W2117687624 @default.
• W4386543503 cites W2138553410 @default.
• W4386543503 cites W2145685053 @default.
• W4386543503 cites W2147059311 @default.
• W4386543503 cites W2158649077 @default.
• W4386543503 cites W2162275372 @default.
• W4386543503 cites W2166095329 @default.
• W4386543503 cites W2168287995 @default.
• W4386543503 cites W2171545300 @default.
• W4386543503 cites W2207116332 @default.
• W4386543503 cites W2234308734 @default.
• W4386543503 cites W2296582418 @default.
• W4386543503 cites W2417193509 @default.
• W4386543503 cites W2605997622 @default.
• W4386543503 cites W2760835120 @default.
• W4386543503 cites W2888555797 @default.
• W4386543503 cites W3004744233 @default.
• W4386543503 cites W3134743179 @default.
• W4386543503 cites W3157172147 @default.
• W4386543503 cites W4205496408 @default.
• W4386543503 cites W4234437314 @default.
• W4386543503 cites W57939698 @default.
• W4386543503 doi "https://doi.org/10.1002/hsr2.1360" @default.
• W4386543503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37692794" @default.
• W4386543503 hasPublicationYear "2023" @default.
• W4386543503 type Work @default.
• W4386543503 citedByCount "0" @default.
• W4386543503 crossrefType "journal-article" @default.
• W4386543503 hasAuthorship W4386543503A5000571424 @default.
• W4386543503 hasAuthorship W4386543503A5022285502 @default.
• W4386543503 hasAuthorship W4386543503A5045149216 @default.
• W4386543503 hasAuthorship W4386543503A5072999518 @default.
• W4386543503 hasAuthorship W4386543503A5092826215 @default.
• W4386543503 hasBestOaLocation W43865435031 @default.
• W4386543503 hasConcept C111472728 @default.
• W4386543503 hasConcept C112698675 @default.
• W4386543503 hasConcept C138885662 @default.
• W4386543503 hasConcept C142724271 @default.
• W4386543503 hasConcept C144133560 @default.
• W4386543503 hasConcept C15744967 @default.
• W4386543503 hasConcept C17744445 @default.
• W4386543503 hasConcept C199539241 @default.
• W4386543503 hasConcept C2776144398 @default.
• W4386543503 hasConcept C2779473830 @default.
• W4386543503 hasConcept C2779530757 @default.
• W4386543503 hasConcept C2779717098 @default.
• W4386543503 hasConcept C2908647359 @default.
• W4386543503 hasConcept C71924100 @default.
• W4386543503 hasConcept C83867959 @default.
• W4386543503 hasConcept C99454951 @default.
• W4386543503 hasConceptScore W4386543503C111472728 @default.
• W4386543503 hasConceptScore W4386543503C112698675 @default.
• W4386543503 hasConceptScore W4386543503C138885662 @default.
• W4386543503 hasConceptScore W4386543503C142724271 @default.
• W4386543503 hasConceptScore W4386543503C144133560 @default.
• W4386543503 hasConceptScore W4386543503C15744967 @default.
• W4386543503 hasConceptScore W4386543503C17744445 @default.
• W4386543503 hasConceptScore W4386543503C199539241 @default.
• W4386543503 hasConceptScore W4386543503C2776144398 @default.
• W4386543503 hasConceptScore W4386543503C2779473830 @default.
• W4386543503 hasConceptScore W4386543503C2779530757 @default.
• W4386543503 hasConceptScore W4386543503C2779717098 @default.
• W4386543503 hasConceptScore W4386543503C2908647359 @default.
• W4386543503 hasConceptScore W4386543503C71924100 @default.
• W4386543503 hasConceptScore W4386543503C83867959 @default.
• W4386543503 hasConceptScore W4386543503C99454951 @default.
• W4386543503 hasIssue "9" @default.
• W4386543503 hasLocation W43865435031 @default.
• W4386543503 hasLocation W43865435032 @default.
• W4386543503 hasOpenAccess W4386543503 @default.
• W4386543503 hasPrimaryLocation W43865435031 @default.
• W4386543503 hasRelatedWork W2181334335 @default.
• W4386543503 hasRelatedWork W2569401834 @default.

• next